These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25254396)

  • 1. [Diabetic cardiomyopathy/heart failure: news regarding etiology, diagnosis, therapy].
    Stratmann B; Worms J; Tschoepe D
    Dtsch Med Wochenschr; 2014 Oct; 139(40):2006-9. PubMed ID: 25254396
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracellular lipid accumulation and shift during diabetes progression.
    Wolf P; Winhofer Y; Anderwald CH; Krššák M; Krebs M
    Wien Med Wochenschr; 2014 Aug; 164(15-16):320-9. PubMed ID: 25047370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Diabetes and Heart Failure Modulate Each Other and Condition Management.
    Randhawa VK; Dhanvantari S; Connelly KA
    Can J Cardiol; 2021 Apr; 37(4):595-608. PubMed ID: 33276047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure.
    Osuna PM; Brown SJ; Tabatabai LS; Hamilton DJ
    Methodist Debakey Cardiovasc J; 2018; 14(4):257-265. PubMed ID: 30788011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes and heart failure: a practically oriented critical appraisal].
    Halle M; Gitt AK; Hanefeld M; Kellerer M; Marx N; Meier JJ; Schumm-Draeger PM; Bramlage P; Tschoepe D
    Dtsch Med Wochenschr; 2012 Mar; 137(9):437-41. PubMed ID: 22354800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From cardiovascular risk to chronic heart failure].
    Ertl G
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():17. PubMed ID: 14694837
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure.
    Dei Cas A; Khan SS; Butler J; Mentz RJ; Bonow RO; Avogaro A; Tschoepe D; Doehner W; Greene SJ; Senni M; Gheorghiade M; Fonarow GC
    JACC Heart Fail; 2015 Feb; 3(2):136-45. PubMed ID: 25660838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
    Khan S; Ahmad SS; Kamal MA
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart Failure in Type 2 Diabetes Mellitus.
    Kenny HC; Abel ED
    Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
    Marwick TH; Ritchie R; Shaw JE; Kaye D
    J Am Coll Cardiol; 2018 Jan; 71(3):339-351. PubMed ID: 29348027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyopathy in type 2 diabetes: update on pathophysiological mechanisms.
    Saunders J; Mathewkutty S; Drazner MH; McGuire DK
    Herz; 2008 Apr; 33(3):184-90. PubMed ID: 18568312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic cardiomyopathy revisited.
    Boudina S; Abel ED
    Circulation; 2007 Jun; 115(25):3213-23. PubMed ID: 17592090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice.
    Kokura S; Adachi S; Manabe E; Mizushima K; Hattori T; Okuda T; Nakabe N; Handa O; Takagi T; Naito Y; Yoshida N; Yoshikawa T
    Int J Hyperthermia; 2007 May; 23(3):259-65. PubMed ID: 17523018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Congestive heart failure and diabetes mellitus: an intricated relationship].
    De Flines J; Scheen AJ
    Rev Med Liege; 2007 Feb; 62(2):112-7. PubMed ID: 17461301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.
    Dhalla NS; Shah AK; Tappia PS
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.
    Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC
    J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cells and diabetic cardiomyopathy: from pathology to therapy.
    Liu M; Chen H; Jiang J; Zhang Z; Wang C; Zhang N; Dong L; Hu X; Zhu W; Yu H; Wang J
    Heart Fail Rev; 2016 Nov; 21(6):723-736. PubMed ID: 27221074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?
    Mizamtsidi M; Paschou SA; Grapsa J; Vryonidou A
    Eur J Clin Invest; 2016 Nov; 46(11):947-953. PubMed ID: 27600276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heartbeat: Diabetes and heart failure.
    Otto CM
    Heart; 2017 Mar; 103(5):327-328. PubMed ID: 28209660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.